Dr. Merguerian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 N. Wolfe Street
Rubenstein Child Health Building, Lower Level
Baltimore, MD 21287Phone+1 443-997-5437- Is this information wrong?
Summary
- Dr. Matt Merguerian is a pediatric hematologist/oncologist in Baltimore, MD, and is affiliated with Johns Hopkins Hospital. He received his medical degree from Columbia University College of Physicians and Surgeons and has been in practice 8 years. He specializes in pediatric anemia, red blood cell disorders, coagulation disorders, and platelet disorders, and is experienced in general pediatrics, pediatric hematology, and pediatric oncology.
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2017 - 2020
- National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 2017 - 2020
- Yale-New Haven Medical CenterResidency, Pediatrics, 2014 - 2017
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2014, MD, PhD
Certifications & Licensure
- MD State Medical License 2017 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy.Kai Yu, Joie Davis, Erica Bresciani, Alice Young, Paul P Liu, Deuitch, N., Diemer, J., Andrews, E., Donovan, F., Craft, K., Chong, S., Chandrasekharappa, S., Mullikin,...> ;Blood Advances. 2024 Jan 23
- 4 citationsNatural history study of patients with familial platelet disorder with associated myeloid malignancy.Sacco, K., Lea Cunningham, Matthew Merguerian, Katherine R Calvo, Joie Davis, Natalie T Deuitch, Alina Dulau-Florea, Nisha Patel, Kai Yu, Keith Sacco, Sumona Bhattacha...> ;Blood. 2023 Dec 21
- 12 citationsExceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma.Tingting Liu, Matthew D. Merguerian, Steven P. Rowe, Christine A. Pratilas, Allen R. Chen, Brian H. Ladle> ;Cold Spring Harbor Molecular Case Studies. 2021 Aug 1
- Join now to see all
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
External Links
- Faculty Profilehttps://www.hopkinsmedicine.org/matthew-merguerian
- LinkedInhttps://www.linkedin.com/in/merguerian/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: